WHO IS MARC VORDERMAN
Picture a digital fossil with a twist, not a relic, but a survivor with pattern recognition. Currently: Director at Global Value Web (GVW).
I come from the age of dot-matrix printers, green screens, and floppy disks, yet I’ve spent the last 2 decades deep in the realities of modern digital transformation: cloud, analytics, predictive thinking, and data-driven decision-making. I’ve lived every phase of the digital evolution, from the screech of dial-up to today’s quiet, always-on data ecosystems, long enough to know the difference between hype and what actually sticks.
My career started early.
1983: junior programmer.
Mid-80s: MRP, MRPII, ERP, deeply embedded in the process industry.
International since 1990, including 12 years in Germany, building and running consulting organizations with 700+ professionals across borders.
Since 2015, my focus has shifted decisively toward data science, analytics, and predictive decision-making, and over time evolved into a broader engagement with digital transformation in pharmaceutical quality, regulatory, and operational environments. Not digitalization as a collection of tools, but as a structural capability built on trusted data, ownership, explainability, and sound decision-making under regulatory pressure.
Much of my work, and writing, revolves around a simple but uncomfortable observation: most organizations don’t fail at digitalization because of technology. They fail because execution, governance, and data coherence are underestimated.
That’s why, when I speak or write about digitalization, I usually start with one question: Are you “Doing Digital,” or are you “Being Digital”?
At a high level:
Doing Digital focuses on efficiency. Automating tasks, digitizing workflows, improving what already exists.
Being Digital is about effectiveness. Designing operations, quality systems, and decision flows around data, not around processes that merely generate it.
This distinction sits at the heart of my publications on Pharma 4.0, control-by-data, compliance-driven innovation, and digital maturity. Whether the topic is IDMP, CPV, PAT/QbD, real-world evidence, or AI in regulated environments, the message is consistent: digital transformation is not a project, a platform, or a pilot; it’s a shift in how organizations see, decide, and act.
I actively publish articles and white papers, and contribute to conferences and executive discussions, translating complex regulatory and data challenges into practical execution models. Not theory for theory’s sake, but frameworks that help organizations move from fragmented initiatives to connected, compliant, and decision-ready operations.
I’ll leave the deep dives to my LinkedIn articles and publications. This page is just the surface.
The short version? I’ve been around long enough to remember why systems were built the way they were, and experienced enough to know why they now need to evolve.
Looking forward meeting you!
IDMP is already being adopted across the pharmaceutical industry as a core enabler of digital transformation - not just a regulatory requirement. By providing a harmonized, machine‑readable structure for medicinal product data, IDMP unlocks true interoperability across regulatory, safety, manufacturing, and supply‑chain systems, enabling consistent data exchange and lifecycle continuity. The EMA notes that IDMP ensures reliable, unambiguous communication of product information, forming the backbone of digital operations.
Industry benchmarks confirm that 89% of companies now consider IDMP central to their digitalization strategy, driving AI readiness, automation, and mature data governance.
This session explores how IDMP transforms compliance into scalable digital capability.
For conference production and speaking opportunites:
Für die Produktion von Konferenzen und die Möglichkeit, Vorträge zu halten:
For sponsorship and exhibition opportunities: